Explore our core engineering capabilities designed to optimize global clinical trials, remote patient management, and smart healthcare ecosystems.
Pioneering high-precision manufacturing for decentralized clinical trial frameworks and telemedicine support systems since 2016.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. In addition to its standard product offerings, the company provides OEM and ODM services tailored to specific research applications and market requirements.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research through innovative technologies that support decentralized studies, patient-centric trial models, and data-driven healthcare innovation worldwide.
Take a visual tour inside our advanced SMT assembly lines, cleanrooms, and stringent quality assurance labs.
Discover our specialized diagnostic monitors, laboratory reagents, and intelligent monitoring accessories.
An authoritative analysis of decentralization in clinical workflows, technological architectures, and regulatory compliance standards.
The global market for telehealth clinical support systems and decentralized clinical trial (DCT) technologies is experiencing exponential compound annual growth. Driven by the imperative for patient-centric research, sponsors increasingly demand custom OEM solutions that reduce geographical barriers to patient recruitment and ensure continuous real-time biometric data telemetry.
From multi-center pharmaceutical trials across North America and Europe to emerging decentralized healthcare frameworks in Asia-Pacific and Latin America, our systems adapt seamlessly to local regulatory paradigms (HIPAA, GDPR, FDA 21 CFR Part 11) while ensuring robust encrypted data pipelines from remote patient homes to centralized hospital databases.
Next-generation clinical support systems integrate edge artificial intelligence, 5G cellular telemetry, and ultra-low-power biosensors. Dongguan Trial Medical leads this transformation by embedding machine-learning anomaly detection directly into wearable monitors, empowering clinicians with predictive insights long before acute clinical events manifest.
Developing robust clinical support infrastructure requires rigorous alignment with medical-grade manufacturing standards. At our 11,000-square-meter Dongguan facility, every production batch undergoes automated optical inspection (AOI), strict calibration protocols, and end-to-end electronic traceability. Whether designing custom multi-parameter patient monitors or secure temperature data loggers for cold-chain pharmaceutical distribution, our OEM/ODM partnership model provides clinical research organizations (CROs) with unmatched scalability, rapid prototyping, and absolute compliance reliability.
Expert answers regarding custom OEM manufacturing, regulatory compliance, and system integration for clinical trials.
We combine over 8 years of specialized R&D experience with an 11,000-square-meter state-of-the-art facility in Dongguan. Our vertically integrated manufacturing model encompasses SMT surface mounting, firmware engineering, rigorous environmental testing, and custom OEM/ODM branding tailored precisely to global regulatory standards.
Our devices utilize end-to-end military-grade encryption (AES-256) for data transmission and cloud storage. System architecture is strictly engineered to comply with FDA 21 CFR Part 11 electronic records requirements and European GDPR patient privacy mandates, ensuring complete audit readiness for clinical trials.
Yes. Our hardware and software solutions support standard medical interoperability protocols including HL7, FHIR, MQTT, and secure RESTful APIs, allowing seamless integration with existing Electronic Health Record (EHR) systems and centralized hospital information command centers.
For standard OEM customization projects, initial prototype development and functional testing typically take 4 to 6 weeks. Following design validation and client approval, mass production cycles range from 8 to 12 weeks depending on order volume and complex hardware-software integration specifications.
Trial Medical
